iRhythm Holdings (IRTC) Restructuring Costs (2022 - 2026)
iRhythm Holdings (IRTC) posted quarterly Restructuring Costs of $11.1 million for Q4 2023, down 58.37% quarter-over-quarter from $26.6 million in Q1 2022.
iRhythm Holdings (IRTC) Restructuring Costs (2022 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported Restructuring Costs for 2 consecutive years, with $11.1 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Restructuring Costs changed N/A year-over-year to $11.1 million; the TTM figure through Dec 2023 stood at $11.1 million (down 58.37% YoY), while the FY2024 annual figure was $641000.0, down 94.21% from the prior year.
- Restructuring Costs retreated to $11.1 million in Q4 2023 per IRTC's latest filing, from $26.6 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $26.6 million in Q1 2022 and bottomed at $11.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn |
| 10 | iRhythm Holdings | 4.19 Bn | 3.60 Bn | 163.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.95 Mn |
| Dec 31, 2023 | 11.08 Mn |
| Mar 31, 2022 | 26.61 Mn |